Reuters logo
BRIEF-ACADIA Pharmaceuticals Q2 loss per share $0.55
2017年8月8日 / 晚上8点42分 / 3 个月前

BRIEF-ACADIA Pharmaceuticals Q2 loss per share $0.55

Aug 8 (Reuters) - ACADIA Pharmaceuticals Inc

* Q2 sales $30.5 million

* Q2 loss per share $0.55

* ACADIA Pharmaceuticals Inc - ‍expects that full-year NUPLAZID net sales for 2017 will be between $105 million and $115 million​

* ACADIA Pharmaceuticals - ‍at June 30, 2017, co's cash, cash equivalents, investment securities totaled $417.3 million, versus $529.0 million at December 31, 2016​ Source text: (bit.ly/2vMFECR) Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below